| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $31.2M | $35.9M | $36.2M |
| YoY Revenue Growth % | -12.9% | -0.9% | — |
| Gross Profit | $15.0M | $14.7M | — |
| Gross Margin % | 48.1% | 40.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.9M | -$19.5M | -$9.9M |
| Operating Margin % | -6.0% | -54.3% | -27.3% |
| Net Income (GAAP) | $42.3K | -$18.9M | -$7.3M |
| EBITDA (Normalized) | -$1.8M | -$19.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.4M | -$11.5M | -$4.8M |
| Capital Expenditures (CapEx) | $56.7K | $75.0K | — |
| Free Cash Flow (FCF) | $2.4M | -$11.5M | -$4.8M |
| FCF Margin % | 7.6% | -32.1% | -13.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $50.9M | $44.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $48.9M | $48.8M | — |